Update on real-world efficacy of anlotinib in non-small cell lung cancer

被引:0
|
作者
Gao, Junzhen
Xu, Yan
Liu, Yonggang
Liang, Li
Yu, Yan
Zhao, Dahai
Jin, Jiahui
Wang, Mengzhao
机构
[1] Inner Mongolia Med Univ, Affiliated Hosp, Hohhot, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China
[3] Baotou Tumor Hosp, Baotou, Peoples R China
[4] Peking Univ Third Hosp, Beijing, Peoples R China
[5] Harbin Med Canc Hosp, Harbin, Peoples R China
[6] Second Affiliated Hosp, Hefei, Peoples R China
[7] Affiliated Qingdao Cent Hosp, Qingdao, Peoples R China
[8] Peking Union Med Coll Hosp, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e21173
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Factors Influencing the Efficacy of Anlotinib in the Treatment of Advanced Non-Small Cell Lung Cancer
    Chen, Fengwu
    Peng, Huarong
    Liu, Haiyun
    Peng, Liming
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2022, 18 (05) : 1071 - 1078
  • [32] Real-World Case Series on Efficacy and Safety of Amivantamab for EGFR-mutant Non-small Cell Lung Cancer
    Le, X.
    Du, R.
    Lewis, W. E.
    Hong, L.
    Skoulidis, F.
    Byers, L.
    Tsao, A.
    Cascone, T.
    Pozadzides, J.
    Tu, J.
    Negrao, M. V.
    Baik, C.
    Zhang, J.
    Heymach, J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S484 - S484
  • [33] The real-world efficacy and safety of anamorelin hydrochloride for Japanese unresectable non-small cell lung cancer patients with cachexia
    Arai, D.
    Kido, R.
    Yamaguchi, J.
    Kamimoto, S.
    Furuya, S.
    Kanzawa, A.
    Miyazaki, M.
    Baba, R.
    Okamori, S.
    Takahashi, H.
    Nakachi, I.
    ANNALS OF ONCOLOGY, 2023, 34 : S1638 - S1639
  • [34] Clinical efficacy and safety of maintenance therapy for advanced non-small cell lung cancer: a retrospective real-world study
    Xu, Xiangwei
    Li, Ruya
    Zhu, Peizhen
    Zhang, Penghai
    Chen, Jun
    Lin, Yongsheng
    Chen, Yinqiao
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [35] Efficacy of neoadjuvant chemo-immunotherapy in non-small cell lung cancer: a real-world, multicenter, retrospective study
    Wang, Xun
    Wang, Xin
    Hui, Bengang
    Cai, Jingsheng
    Zhao, Heng
    Qiao, Bowei
    Duan, Jiangnan
    Chen, Kezhong
    Wang, Jun
    Lei, Jie
    Yang, Fan
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (04) : 849 - 860
  • [36] Real-world Efficacy of Dacomitinib in Patients with Previously EGFR-TKI Treated Non-small Cell Lung Cancer
    Chi, C. -Y.
    Chiang, C. -L.
    Chen, Y. -M.
    Luo, Y. -H.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S467 - S467
  • [37] Real-World Analysis of Nivolumab and Atezolizumab Efficacy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
    Alonso-Garcia, Miriam
    Sanchez-Gastaldo, Amparo
    Munoz-Fuentes, Miguel A.
    Molina-Pinelo, Sonia
    Boyero, Laura
    Benedetti, Johana Cristina
    Bernabe-Caro, Reyes
    PHARMACEUTICALS, 2022, 15 (05)
  • [38] Efficacy of dacomitinib in patients with non-small cell lung cancer carrying complex EGFR mutations: a real-world study
    Li, Hong-Shuai
    Li, Jun-Ling
    Yan, Xiang
    Xu, Hai-Yan
    Zhou, Li-Qiang
    Hu, Xing-Sheng
    Wang, Yu-Ying
    Lei, Si-Yu
    Wang, Yan
    JOURNAL OF THORACIC DISEASE, 2022, 14 (05) : 1428 - +
  • [39] Clinical efficacy and safety of maintenance therapy for advanced non-small cell lung cancer: a retrospective real-world study
    Xiangwei Xu
    Ruya Li
    Peizhen Zhu
    Penghai Zhang
    Jun Chen
    Yongsheng Lin
    Yinqiao Chen
    World Journal of Surgical Oncology, 19
  • [40] Real-world outcomes in patients with unresected stage III non-small cell lung cancer
    Ryan, Kellie J.
    Skinner, Karen E.
    Fernandes, Ancilla W.
    Punekar, Rajeshwari S.
    Pavilack, Melissa
    Walker, Mark S.
    VanderWalde, Noam A.
    MEDICAL ONCOLOGY, 2019, 36 (03)